What is Zovirax?
Zovirax is a 5% aciclovir cream that treats genital herpes outbreaks caused by the herpes simplex virus (HSV). It works best when applied as soon as you notice the first signs of an outbreak, like tingling or redness.
It can be used during both first and recurrent episodes. Research has shown that it can significantly shorten healing time, reduce the spread of the virus, and ease symptoms, compared to no treatment or placebo.[1]
How does Zovirax work for genital herpes?
Aciclovir, the active ingredient in Zovirax, works by interfering with the virus’s ability to reproduce. Once you apply it, it’s absorbed into infected skin cells and works to block the virus from replicating. This helps to stop the virus from spreading further, while allowing your skin to heal more quickly.[1]
Zovirax also reduces the amount of virus that gets shed from the skin, which helps lower the chance of passing it on to someone else.[1]
Will I get side effects using Zovirax?
Side effects from Zovirax are rare and usually mild. Some people might notice a temporary stinging or burning feeling when it’s first applied.
Allergic reactions are very rare, but if you experience swelling, itching, or a rash that spreads beyond your treatment area, you should stop using it and speak to a clinician.
What doses of Zovirax are there?
Zovirax comes as a 5% cream. Aciclovir, the active ingredient in Zovirax, is also available in an oral tablet form.
Treated trusted source:
- Kinghorn, G.R., Barbara Turner, E., Barton, I.G., Potter, C.W., Burke, C.A. and Fiddian, A.Paul. (1983). Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes. Antiviral Research, 3(5-6), pp.291–301.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.